Inhibition, ADME and structure based modification of IAA and IBA against acetylcholinesterase: an attempt towards new drug development for Alzheimer's disease

Author： Dileep K.V.   Remya C.   Tintu I.   Sadasivan C.  

Publisher： Taylor & Francis Ltd

ISSN： 2155-3769

Source： Frontiers in Life Science, Vol.7, Iss.3-4, 2013-12, pp. : 164-173

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Inhibition of Acetylcholinesterase (AChE): A Potential Therapeutic Target to Treat Alzheimer's Disease

By  

CHEMICAL BIOLOGY & DRUG DESIGN (ELECTRONIC), Vol. 1747-0277, Iss. 4, 2015-10 ,pp. : 776-782

John Wiley & Sons Inc

Access to resources Recommend Favorite

Inhibition of Acetylcholinesterase (AChE): A Potential Therapeutic Target to Treat Alzheimer's Disease

By  

CHEMICAL BIOLOGY & DRUG DESIGN (ELECTRONIC), Vol. 86, Iss. 4, 2015-10 ,pp. : 776-782

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is riluzole a new drug for Alzheimer's disease?

By  

JOURNAL OF NEUROCHEMISTRY (ELECTRONIC), Vol. 22-3042, Iss. 2, 2015-10 ,pp. : 207-209

John Wiley & Sons Inc

Access to resources Recommend Favorite

The role of quantitative ADME proteomics to support construction of physiologically based pharmacokinetic models for use in small molecule drug development

By  

PROTEOMICS - CLINICAL APPLICATIONS, Vol. 9, Iss. 7-8, 2015-08 ,pp. : 732-744

John Wiley & Sons Inc

Access to resources Recommend Favorite

ACE Inhibition with Captopril Retards the Development of Signs of Neurodegeneration in an Animal Model of Alzheimer’s Disease

By AbdAlla Said   Langer Andreas   Fu Xuebin   Quitterer Ursula  

International Journal of Molecular Sciences, Vol. 14, Iss. 8, 2013-08 ,pp. : 16917-16942

MDPI

Access to resources Recommend Favorite